Axillary Lymph Node Status and neoadjuvant Therapy in HER2-positive Breast Cancer

被引：0
|
作者：
Danzinger, Autoren S. [1 ]
Pfeifer, C. [2 ]
Wimmer, S. [1 ]
Tendl-Schulz, K. [3 ]
Singer, C. F. [1 ]
机构：
[1] Med Univ Wien, Inst Univ Klin Frauenheilkunde 1, Vienna, Austria
[2] Univ Innsbruck, Inst Stat, Innsbruck, Austria
[3] Med Univ Wien, Klin Inst Pathol, Vienna, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2021年 / 81卷 / 04期
关键词：
D O I：
10.1055/s-0041-1726593
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
16
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [31] Trastuzumab-Based Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer
    Chang, Helena R.
    CANCER, 2010, 116 (12) : 2856 - 2867
  • [32] Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy
    Guiu, S.
    Reynier, M. A. Mouret
    Toure, M.
    Coudert, B.
    JOURNAL OF ONCOLOGY, 2013, 2013
  • [33] ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy
    Li, Jian-wei
    Mo, Miao
    Yu, Ke-da
    Chen, Can-ming
    Hu, Zhen
    Hou, Yi-feng
    Di, Gen-hong
    Wu, Jiong
    Shen, Zhen-zhou
    Shao, Zhi-ming
    Liu, Guang-yu
    PLOS ONE, 2014, 9 (12):
  • [34] Discrepancy of pathologic complete response and outcome between breast tumor and axillary node in HER2-positive breast cancer after neoadjuvant chemotherapy.
    Chu, Chia-Hui
    Chen, Shin-Cheh
    Chang, Hsien-Kun
    Lin, Yung-Chang
    Shen, Shih-Che
    Kuo, Wen-Lin
    Yu, Chi-Chang
    Chou, Hsu-Huan
    Huang, Yi-Ting
    Ueng, Shir-Hwa
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 28 - 29
  • [35] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [36] Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
    Wang, Mengshen
    Wang, Mozhi
    Wang, Zhenning
    Song, Yongxi
    Gao, Peng
    Wang, Pengliang
    Wang, Chong
    Yu, Xueting
    Wei, Fengheng
    Guo, Jingyi
    Xu, Yingying
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 7054 - 7064
  • [37] Adjuvant Therapy for HER2-Positive Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (12): : 1134 - 1134
  • [38] Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy
    Mou, Exian
    Ji, Juan
    Liu, Shiwei
    Shu, Lan
    Zou, Liqun
    Li, Zhuoxuan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Targeted Therapy in HER2-Positive Breast Cancer
    Thill, Marc
    Kraft, Clayton
    Friedrich, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (05) : 295 - 302
  • [40] Therapy for HER2-Positive Metastatic Breast Cancer
    Dekker, Tim J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
12345